- Trials with a EudraCT protocol (84)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
84 result(s) found for: Information processing.
Displaying page 1 of 5.
EudraCT Number: 2012-002476-14 | Sponsor Protocol Number: 17/13/03/03/2012 | Start Date*: 2013-02-15 |
Sponsor Name:Jesper Ekelund | ||
Full Title: The effect of various medications on emotioal processing, attention, experiences and sensory information processing | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005205-71 | Sponsor Protocol Number: FCE2011 | Start Date*: 2012-04-24 |
Sponsor Name:Leiden University [...] | ||
Full Title: The effect of fludrocortisone on emotional information processing in healthy volunteers | ||
Medical condition: None. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-005739-91 | Sponsor Protocol Number: AGO/2005/006 | Start Date*: 2006-06-21 |
Sponsor Name:University Hospital Ghent | ||
Full Title: Functional Neuroimaging in depression: longitudinal study of PET metabolism in correlation with changes in attentional bias, autobiographical memory, future fluency and facial recognition in depres... | ||
Medical condition: Major depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-005307-42 | Sponsor Protocol Number: S2540345 | Start Date*: 2006-01-03 |
Sponsor Name:GlaxoSmithKline Consumer Healthcare | ||
Full Title: An evaluation of the 4 mg nicotine mint lozenge for the relief of cognitive impairment associated with nicotine withdrawal. | ||
Medical condition: Nicotine dependence. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004357-82 | Sponsor Protocol Number: OSU6162ME1 | Start Date*: 2012-02-21 |
Sponsor Name:A. Carlsson Research AB | ||
Full Title: A randomized controlled trial of OSU6162 in treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | ||
Medical condition: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003331-10 | Sponsor Protocol Number: HC03 | Start Date*: 2017-10-16 |
Sponsor Name:Leiden University | ||
Full Title: Acute effects of 40 mg cortisol on emotion and cognition. | ||
Medical condition: None. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-002070-23 | Sponsor Protocol Number: EEGrofl | Start Date*: 2011-10-12 |
Sponsor Name:Maastricht University Medical Center | ||
Full Title: Effects of roflumilast on cognition in healthy adults: a behaviour-EEG study | ||
Medical condition: None; this proof-of-principle study will examine the cognition enhancing effects of roflumilast in healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2010-024364-18 | Sponsor Protocol Number: coneara | Start Date*: 2011-04-12 | ||||||||||||||||
Sponsor Name:Leiden University [...] | ||||||||||||||||||
Full Title: The effects of ARA290 on the cognitive and neural processing of emotions in healthy volunteers | ||||||||||||||||||
Medical condition: emotional information processing. (Disease of interest is depression, however this trial is in healthy volunteers; we will use a test battery that has previously been shown sensitive to the admin... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000925-60 | Sponsor Protocol Number: R1/11 | Start Date*: 2011-10-18 |
Sponsor Name:Kungälv Hospital | ||
Full Title: Effect of treatment with methylphenidate on mental fatigue (“brain fatigue”) and pain on persons who have suffered a traumatic brain injury or whip lash injury – a pilot study. | ||
Medical condition: Mental fatigue after traumatic brain injury or whip-lash injury | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001650-29 | Sponsor Protocol Number: MF02/11 | Start Date*: 2011-12-19 |
Sponsor Name:A. Carlsson Research AB | ||
Full Title: TREATMENT OF MENTAL FATIGUE ("BRAIN FATIGUE") WITH THE DOPAMINERGIC STABILIZER OSU6162 AFTER STROKE AND MILD/MODERATE TRAUMATIC BRAIN INJURY– INCREASE OF PATIENT NUMBER | ||
Medical condition: Mental fatigue after stroke or mild to moderate head trauma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003728-39 | Sponsor Protocol Number: OTMother2014 | Start Date*: 2014-12-16 |
Sponsor Name:Tampere University Hospital | ||
Full Title: Effects of maternal oxytocin on social information processing in mothers | ||
Medical condition: There are no medical conditions or diseases under investigation, participants are healthy volunteers. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000444-84 | Sponsor Protocol Number: EMR62225-030 | Start Date*: 2005-06-22 |
Sponsor Name:Merck KGaA | ||
Full Title: An open-label, multicenter, multinational Phase III follow-up study to investigate the long-term safety and efficacy of Sarizotan HCl 1 mg b.i.d. in patients with Parkinson's disease suffering from... | ||
Medical condition: Treatment-Associated Dyskinesia in Parkinson's Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) FI (Prematurely Ended) GB (Completed) IT (Prematurely Ended) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001539-39 | Sponsor Protocol Number: NV18-04-00260 | Start Date*: 2019-06-17 |
Sponsor Name:Národní ústav duševního zdraví | ||
Full Title: Clinical and neurobiological predictors of response to ketamine: towards personalized treatment of depression | ||
Medical condition: Moderate to severe depression without psychotic symptoms | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000182-31 | Sponsor Protocol Number: CHDR1438 | Start Date*: 2015-02-11 |
Sponsor Name:CHDR | ||
Full Title: A randomized, double-blind, placebo-controlled, cross-over study to assess the effects of fampridine on eye movements and nerve conduction in patients with multiple sclerosis (MS) and a unilateral ... | ||
Medical condition: Multiple sclerosis (MS) and a unilateral or bilateral internuclear ophthalmoplegia (INO) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001839-23 | Sponsor Protocol Number: 14137A | Start Date*: 2012-05-14 |
Sponsor Name:H. Lundbeck A/S | ||
Full Title: Interventional randomised, double-blind, parallel-group, placebo-controlled, exploratory study investigating the effects of Lu AA21004 on cognition and BOLD fMRI signals in subjects remitted fro... | ||
Medical condition: Cognitive dysfunction Major depressive disorder (MDD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004854-25 | Sponsor Protocol Number: SPON803-10 | Start Date*: 2012-01-10 | |||||||||||
Sponsor Name:Cardiff University | |||||||||||||
Full Title: TRON: A randomised, double blind, placebo-controlled study of RAD001 (Everolimus) in the treatment of neurocognitive problems in tuberous sclerosis. | |||||||||||||
Medical condition: Tuberous Sclerosis Complex (TSC) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000235-28 | Sponsor Protocol Number: 190-060 | Start Date*: 2004-10-27 |
Sponsor Name:Sepracor Inc. | ||
Full Title: The effects of a single evening dose of 3mg eszopiclone on next day driving ability and psychomotor/memory function in patients with primary insomnia compared to placebo | ||
Medical condition: Insomnia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001012-19 | Sponsor Protocol Number: CFTY720DNL02T | Start Date*: 2014-12-17 |
Sponsor Name:VU University Medical Center | ||
Full Title: Effects of fingolimod on functional brain adaptation and clinical measures in multiple sclerosis | ||
Medical condition: Relapsing-remitting (RR) multiple sclerosis (MS) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002386-18 | Sponsor Protocol Number: 11-185/CAIAC | Start Date*: 2016-03-15 |
Sponsor Name:RWTH Aachen Clinical Trials Center Aachen (CTC-A) | ||
Full Title: Network connectivity and inhibitory control under atomoxetin challenge - A pharamacological "resting state" and "inhibitory task" fMRI study in patients with ADHD | ||
Medical condition: Patients with Attention-Deficit/Hyperactivity Disorders (ADHD) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-005431-13 | Sponsor Protocol Number: OTMother2015 | Start Date*: 2015-01-13 |
Sponsor Name:Tampere University Hospital | ||
Full Title: Effects of maternal oxytocin on social information processing in mothers and infants | ||
Medical condition: There are no medical conditions or diseases under investigation, participants are healthy volunteers. | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18, Adults | Gender: Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
